Ballentine Partners, LLC Edwards Lifesciences Corp Transaction History

Ballentine Partners, LLC

  • $5.81 Billion
  • Q4 2024

A detailed history of Ballentine Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 5,484 shares of EW stock, worth $394,628. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,484
Previous 4,674 17.33%
Holding current value
$394,628
Previous $308,000 31.49%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
BUY
$64.54 - $75.92 $52,277 - $61,495
810 Added 17.33%
5,484 $405,000
Q3 2024

Oct 23, 2024
SELL
$59.7 - $93.78 $39,999 - $62,832
-670 Reduced 12.54%
4,674 $308,000
Q2 2024

Aug 06, 2024
BUY
$84.3 - $94.31 $9,104 - $10,185
108 Added 2.06%
5,344 $493,000
Q1 2024

Apr 11, 2024
BUY
$72.54 - $95.56 $71,379 - $94,031
984 Added 23.14%
5,236 $500,000
Q4 2023

Jan 23, 2024
SELL
$61.71 - $77.76 $51,281 - $64,618
-831 Reduced 16.35%
4,252 $324,000
Q3 2023

Oct 19, 2023
SELL
$69.28 - $93.38 $39,489 - $53,226
-570 Reduced 10.08%
5,083 $352,000
Q2 2023

Jul 26, 2023
BUY
$81.41 - $94.33 $14,979 - $17,356
184 Added 3.36%
5,653 $533,000
Q1 2023

Apr 27, 2023
BUY
$74.26 - $84.51 $41,808 - $47,579
563 Added 11.48%
5,469 $452,000
Q4 2022

Jan 27, 2023
BUY
$68.3 - $87.44 $60,240 - $77,122
882 Added 21.92%
4,906 $0
Q3 2022

Oct 26, 2022
BUY
$82.37 - $107.29 $81,628 - $106,324
991 Added 32.67%
4,024 $333,000
Q2 2022

Aug 09, 2022
BUY
$86.5 - $128.27 $76,639 - $113,647
886 Added 41.27%
3,033 $288,000
Q1 2022

May 05, 2022
BUY
$101.96 - $128.34 $28,548 - $35,935
280 Added 15.0%
2,147 $252,000
Q4 2021

Feb 14, 2022
BUY
$106.37 - $130.68 $531 - $653
5 Added 0.27%
1,867 $242,000
Q3 2021

Oct 27, 2021
BUY
$102.91 - $122.75 $191,618 - $228,560
1,862 New
1,862 $211,000
Q4 2020

Jan 25, 2021
SELL
$71.69 - $91.23 $318,805 - $405,699
-4,447 Closed
0 $0
Q3 2020

Oct 22, 2020
SELL
$67.19 - $87.44 $64,502 - $83,942
-960 Reduced 17.75%
4,447 $355,000
Q2 2020

Jul 31, 2020
BUY
$57.54 - $76.95 $208,697 - $279,097
3,627 Added 203.76%
5,407 $374,000
Q1 2020

Apr 23, 2020
SELL
$52.41 - $81.0 $5,031 - $7,776
-96 Reduced 5.12%
1,780 $335,000
Q3 2019

Oct 21, 2019
BUY
$61.55 - $75.43 $7,816 - $9,579
127 Added 7.26%
1,876 $412,000
Q2 2019

Jul 25, 2019
BUY
$55.74 - $64.41 $26,587 - $30,723
477 Added 37.5%
1,749 $323,000
Q1 2019

May 09, 2019
BUY
$47.89 - $64.05 $60,916 - $81,471
1,272 New
1,272 $243,000

Others Institutions Holding EW

# of Institutions
1,380
Shares Held
485M
Call Options Held
6.71M
Put Options Held
3.17M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email